-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
LogicBio Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2017 to Q3 2022.
- LogicBio Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$5.78M, a 43.3% increase year-over-year.
- LogicBio Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$26.5M, a 29.9% increase year-over-year.
- LogicBio Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$40M, a 22.7% decline from 2020.
- LogicBio Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$32.6M, a 18.7% increase from 2019.
- LogicBio Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$40.1M, a 128% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)